Clinical trial
Neuroinflammation, White Matter Integrity, AD Biomarkers and Pathology in Corticobasal Syndrome
NCT07000851 is registered in ClinicalTrials.gov with Jennifer Whitwell as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neuroinflammation, White Matter Integrity, AD Biomarkers and Pathology in Corticobasal Syndrome
- Lead sponsor
- Jennifer Whitwell
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 25, 2025
- Completion date
- March 30, 2031
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cortico basal degeneration, corticobasal degeneration, corticobasal degeneration (cbd), corticobasal syndrome, corticobasal syndrome (cbs), corticobasal syndrome(cbs)